ANEPHLA
Mitsubishi Tanabe Pharma Corporation
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85152503 |
| Registration Number | 3961874 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Sarah Anne Keefe |
| Attorney Name | Sarah Anne Keefe |
| Attorney Docket Number | 51713.0001.2 |
| Law Office Assigned | L60 |
| Employee Name | AYALA, LOURDES |
Timeline
| 2010-10-14 | Application Filed |
| 2011-03-01 | Published for Opposition |
| 2011-05-17 | Location: PUBLICATION AND ISSUE SECTION |
| 2011-05-17 | Trademark Registered |
| 2017-12-22 | Cancelled |
| 2017-12-22 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Mitsubishi Tanabe Pharma Corporation |
| Address | 2-6-18, Kitahama, Chuo-ku Osaka JP 541-8505 |
| Legal Entity Type | Corporation |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations, namely, preparations for the treatment, control and prevention of human disorders and diseases resulting from hyperphosphatemia, hyperlipidemia, hypercholestrolemia, hyperparathyroidism, kidney dysfunction, and neurological, genetic, cardiovascular, gastrointestinal, urological, metabolic diabetic, allergy, obesity, and insulin resistance syndromes and conditions |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2010-10-18 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2010-10-19 | 2 NWOS I:Incoming Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2010-11-08 | 3 PARI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2010-11-22 | 4 ALIE A:Allowance for Publication |
| APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2010-11-23 | 5 AMPX O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2011-01-25 | 6 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2011-01-26 | 7 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2011-01-26 | 8 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2011-01-26 | 9 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2011-01-26 | 10 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2011-01-26 | 11 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2011-01-27 | 12 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2011-03-01 | 13 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2011-03-01 | 14 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2011-05-17 | 15 R.PR A:Allowance for Publication |
| CANCELLED SEC. 8 (6-YR) | 2017-12-22 | 16 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ANEPHLA 85152503 3961874 Dead/Cancelled |
Mitsubishi Tanabe Pharma Corporation 2010-10-14 |
 ANEPHLA 77431675 not registered Dead/Abandoned |
Mitsubishi Tanabe Pharma Corporation 2008-03-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 